Participants

Meeting Co-Chairs

Jeff Abrams, M.D.
National Cancer Institute

Paul Andrews, Ph.D.
U.S. Food and Drug Administration

Wadih Arap, M.D., Ph.D.
University of Texas

Susan G. Arbuck, M.D.
National Cancer Institute

James P. Basilion, Ph.D.
Harvard University

William R. Berry, M.D.
US Oncology

William H. Blair, M.S.
Prostate Cancer Advocate

Otis W. Brawley, M.D.
National Cancer Institute

Diane Bronzert
National Cancer Institute

Bruce D. Cheson, M.D.
National Cancer Institute

Judy H. Chiao, M.D.
U.S. Food and Drug Administration

Michaele C. Christian, M.D.
National Cancer Institute

Leland W.K. Chung, Ph.D.
University of Virginia

Laurence P. Clarke, Ph.D.
National Cancer Institute

Barbara A. Conley, M.D.
National Cancer Institute

Richard L. Cumberlin, M.D.
National Cancer Institute

William Dahut, M.D.
National Cancer Institute

Nancy A. Dawson, M.D.
University of Maryland

William Dehn
Prostate Forum

Mario Eisenberger, M.D.
Johns Hopkins University

Ellen G. Feigal, M.D.
National Cancer Institute

William Figg, Pharm.D.
National Cancer Institute

Boris Freidlin, Ph.D.
National Cancer Institute

John Frelinger, Ph.D.
University of Rochester

Alan Fritzberg, Ph.D.
NeoRx Corporation

John Gillespie, M.D.
National Cancer Institute

Jorge Gomez, M.D., Ph.D.
National Cancer Institute

Mary Gospodarowicz, M.D.
Princess Margaret Hospital

Joe W. Gray, Ph.D.
University of California

Jeff Green, M.D.
National Cancer Institute

Louise B. Grochow, M.D.
National Cancer Institute

Paul H. Gumerlock, Ph.D.
University of California

Randall A. Hawkins, M.D., Ph.D.
University of California

Donald Henson, M.D.
National Cancer Institute

John M. Hoffman, M.D.
National Cancer Institute

John T. Isaacs, Ph.D.
Johns Hopkins University

William B. Isaacs, Ph.D.
Johns Hopkins University

James W. Jacobson, Ph.D.
National Cancer Institute

Philip W. Kantoff, M.D.
Dana-Farber Cancer Institute

Adam S. Kibel, M.D.
Washington

Hsing-Jien Kung, Ph.D.
University of California

John Kurhanewicz, Ph.D.
University of California

Lucia R. Languino, Ph.D.
Yale University

Steven M. Larson, M.D.
Memorial Sloan-Kettering Cancer Center

Ronald Lieberman, M.D.
National Cancer Institute

Christopher Logothetis, M.D.
University of Texas

Lynn M. Matrisian, Ph.D.
Vanderbilt University

David McGuinn, Ph.D.
U.S. Food and Drug Administration

Beverly Meadows, R.N., M.S., O.C.N.
National Cancer Institute

Anne Menkens, Ph.D.
National Cancer Institute

Gary J. Miller, M.D., Ph.D.
University of Colorado

William C. Nelson, M.D., Ph.D.
Johns Hopkins University

Blake Lee Neubauer, Ph.D.
Lilly Research Laboratories

Thomas F. Pajak, Ph.D.
American College of Radiology

J. Thomas Parsons, Ph.D.
University of Virginia

Daniel P. Petrylak, M.D.
Columbia Presbyterian Medical Center

Kenneth J. Pienta, M.D.
University of Michigan

Henry A. Porterfield
US TOO International

Thomas G. Pretlow, M.D.
Case Western Reserve University

Pat Price, M.D.
Imperial College

Derek Raghavan, M.D., Ph.D.
University of Southern California

Bruce J. Roth, M.D.
Vanderbilt University

Howard Sandler, M.D.
University of Michigan

Charles L. Sawyers, M.D.
University of California

Scott Saxman, M.D.
National Cancer Institute

Howard Scher, M.D.
Memorial Sloan-Kettering Cancer Center

Neil Senzer, M.D.
US Oncology

Jonathan W. Simons, M.D.
Johns Hopkins University

Edward V. Staab, M.D.
National Cancer Institute

Martin Tenniswood, Ph.D.
University of Notre Dame

Clifford G. Tepper, Ph.D.
University of California

Timothy C. Thompson, Ph.D.
Baylor College of Medicine

Thea D. Tlsty, Ph.D.
University of California

Richard S. Ungerleider, M.D.
National Cancer Institute

Mukesh Verma, Ph.D.
National Cancer Institute

Ralph Weissleder, M.D., Ph.D.
Center for Molecular Imaging Research

George Wilding, M.D.
University of Wisconsin

Robert E. Wittes, M.D.
National Cancer Institute

Mary K. Wolpert, Ph.D.
National Cancer Institute

Roy S. Wu, Ph.D.
National Cancer Institute

Bruce R. Zetter, Ph.D.
Harvard

James A. Zwiebel, M.D.
National Cancer Institute

top of page